The Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) have announced the launch of a next-generation universal vaccine platform aimed at combating pandemic-prone viruses. This initiative includes a significant investment of $500 million, which was redirected from previous COVID-19 funding efforts. The move has garnered attention due to its potential to develop vaccines targeting multiple virus strains, including flu and coronaviruses. Notably, this strategy represents a shift in US vaccine policy as RFK Jr. places a substantial bet on the success of universal vaccines. Critics have raised concerns regarding the bypassing of standard reviews for this project. Meanwhile, HHS officials have downplayed the future of seasonal COVID-19 shots amidst the new focus on universal vaccine development.